Brain tumor initiating cells adapt to restricted nutrition through preferential glucose uptake. - Wikidata - awgldk - TriplyDB

Brain tumor initiating cells adapt to restricted nutrition through preferential glucose uptake.

Brain tumor initiating cells adapt to restricted nutrition through preferential glucose uptake.

http://www.wikidata.org/entity/Q30572367

about

Molecular basis of ligand recognition and transport by glucose transporters Metabolic, autophagic, and mitophagic activities in cancer initiation and progression Cancer stem cell metabolism The Androgen Receptor Bridges Stem Cell-Associated Signaling Nodes in Prostate Stem Cells The Warburg effect and drug resistance Cancer stem cell targeted therapy: progress amid controversies.Novel therapeutic targets of tumor metabolism The mitotic kinesin KIF11 is a driver of invasion, proliferation, and self-renewal in glioblastoma.Glucose transport: meeting the metabolic demands of cancer, and applications in glioblastoma treatment Serine/Threonine Kinase MLK4 Determines Mesenchymal Identity in Glioma Stem Cells in an NF-κB-dependent Manner.Phage display discovery of novel molecular targets in glioblastoma-initiating cells Increased cancer stem cell invasion is mediated by myosin IIB and nuclear translocation Mitochondrial control by DRP1 in brain tumor initiating cells.Head and Neck Squamous Cell Carcinoma Metabolism Draws on Glutaminolysis, and Stemness Is Specifically Regulated by Glutaminolysis via Aldehyde Dehydrogenase Autocrine regulation of glioma cell proliferation via pHe-sensitive K(+) channels Nicotinamide metabolism regulates glioblastoma stem cell maintenance.Cancer stem cell-specific scavenger receptor CD36 drives glioblastoma progression.GLUT3 is induced during epithelial-mesenchymal transition and promotes tumor cell proliferation in non-small cell lung cancer.The anti-hypertensive drug prazosin inhibits glioblastoma growth via the PKCδ-dependent inhibition of the AKT pathway.Molecular targeting of TRF2 suppresses the growth and tumorigenesis of glioblastoma stem cells.Cancer stem cells from epithelial ovarian cancer patients privilege oxidative phosphorylation, and resist glucose deprivation.Mechanisms of glioma formation: iterative perivascular glioma growth and invasion leads to tumor progression, VEGF-independent vascularization, and resistance to antiangiogenic therapy.Attacking the supply wagons to starve cancer cells to death.Impact of outdated gene annotations on pathway enrichment analysis.Glial progenitors as targets for transformation in glioma.EZH2 protects glioma stem cells from radiation-induced cell death in a MELK/FOXM1-dependent manner The metabolic state of cancer stem cells-a valid target for cancer therapy?Targeting the facilitative glucose transporter GLUT1 inhibits the self-renewal and tumor-initiating capacity of cancer stem cells.Glucose-based regulation of miR-451/AMPK signaling depends on the OCT1 transcription factor.ROCK Inhibition Facilitates In Vitro Expansion of Glioblastoma Stem-Like Cells.Ibuprofen and Diclofenac Restrict Migration and Proliferation of Human Glioma Cells by Distinct Molecular Mechanisms.Cancer stem cells in glioblastoma CDC20 maintains tumor initiating cells.Glioma Cells in the Tumor Periphery Have a Stem Cell Phenotype A mathematical model of pre-diagnostic glioma growth.Mitochondrial-Targeted Decyl-Triphenylphosphonium Enhances 2-Deoxy-D-Glucose Mediated Oxidative Stress and Clonogenic Killing of Multiple Myeloma Cells Preferential Iron Trafficking Characterizes Glioblastoma Stem-like Cells Inhibition of RSK with the novel small-molecule inhibitor LJI308 overcomes chemoresistance by eliminating cancer stem cells.Monitoring cancer stem cells: insights into clinical oncology.Patient-Derived Xenografts as a Model System for Radiation Research

P2860

Q24338453-07151174-C023-4D0F-8343-BEF6929F6772 Q26745503-82AB0256-14DD-4856-8701-7C1D666AC0DC Q26746123-33593A10-5B04-4340-A682-BDCBF0F2906E Q26765892-F8E3DC13-F0FA-42CE-BA60-A347799426F0 Q26770007-B6B34F55-9096-4C32-BD56-35D7FADF1464 Q26779931-2702C43C-5661-484C-B781-DEAAF493D04B Q27005930-4268BB54-F7E1-4811-A45D-7883F2135EC7 Q27324657-6D520746-B105-4C8A-9653-A4DB49EE59C3 Q28078559-997F8F26-F4D4-4A1A-91F8-1798A573ABA9 Q28115436-AEF6CB6C-CB00-478C-8E25-AA6FB9BC9340 Q28240138-C266476B-0121-4479-A8B9-BCF2188EF78D Q28917147-FECF5CF8-66FF-459E-A1E2-D1FC53F4B0A5 Q30300490-ED361E93-D207-464B-9C13-B173F79A6110 Q33636562-58E37B24-C498-40DC-8228-DB7B60E7385C Q33702889-3E20E3C6-AB7E-4E05-89F5-59F761877B1A Q33703205-610DFA43-1C45-4425-8083-3976BE368F86 Q33779353-D71ADB06-66A7-4047-AFF7-A6F4D34CB8C3 Q34003440-F1D13AC8-7013-40F7-AAB1-9AD17F508E50 Q34046737-E2F8BAB3-95E4-4F70-B9CB-619638B810DF Q34076281-D9489E42-C689-4B6C-B33A-CBA67B5ABA9A Q34100946-554C7D17-EA99-4733-BAC8-54F5C2CD754A Q34347733-69193F0C-5DB7-4865-8376-2F5E3A4A0CE4 Q34516773-73BD76C3-7D26-488A-85C5-DEF39B0E8DAE Q34538918-56D04EFB-670C-4CB5-8CDB-01DF437CD153 Q34735661-BAE73E15-4483-405A-A4E9-77182FE9098D Q35075212-C1D6151D-126D-4D8C-AE2B-04A42BF3F722 Q35118801-48644B73-51B8-4649-BE20-FF9D52FD2CDB Q35176105-29E5EAA9-FF25-4576-A1A3-1223CD79D797 Q35607018-823137E7-094C-47BE-B4CE-5A21B2067630 Q35689520-FB111181-317E-4259-B432-DF965D18F335 Q35814510-E00A47AD-D861-4865-B55F-BDBF06DFED5D Q35829972-2445C8AA-FED5-4EDB-95EA-F0B5F14FB9E6 Q35955263-CDF7EE47-62D3-434A-9172-01DA09F3C653 Q36015831-A3174985-C7CF-49C8-B7CE-F9B954D5C609 Q36145414-6D5D5B53-2F47-4334-A8B9-D34DB17A7DE5 Q36208283-BCAF97C2-6A6D-476D-8E82-27147463A576 Q36282985-B4849716-5719-4B76-8604-BC6F31972938 Q36299754-C1A1F093-B620-4F0F-8BA8-99A2B29D3B6D Q36585140-44A8A2C6-4FB9-4B49-9521-69CC0EA16059 Q36592961-8DCEEF54-C2CC-49CE-BF4F-A6AF826CFE63

P2860

Brain tumor initiating cells adapt to restricted nutrition through preferential glucose uptake.

http://www.wikidata.org/entity/Q30572367

description

2013 nî lūn-bûn

@nan

2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Brain tumor initiating cells a ...... h preferential glucose uptake.

@ast

Brain tumor initiating cells a ...... h preferential glucose uptake.

@en

type

label

Brain tumor initiating cells a ...... h preferential glucose uptake.

@ast

Brain tumor initiating cells a ...... h preferential glucose uptake.

@en

prefLabel

Brain tumor initiating cells a ...... h preferential glucose uptake.

@ast

Brain tumor initiating cells a ...... h preferential glucose uptake.

@en

P1433

Q30572367-35FD1143-FBDE-4DC2-B096-9F388F648F32

P1476

Q30572367-9B0C6820-BA82-48F1-88BD-BD78E0864620

P2093

Q30572367-11415A02-7CD0-4E75-ACF5-5293F54D9C2F

Q30572367-1826F13C-234E-424B-8E62-CA5E6F477833

Q30572367-57657639-906F-43F3-9A1E-DB583CD8745C

Q30572367-5D681B49-CDF2-45E6-AAF2-06CD6CFCCF5E

Q30572367-75BA3EEC-86A9-421F-943E-955675041F6C

Q30572367-836D8ADD-1DCB-47EF-9E17-939813240830

Q30572367-8ADE41B5-33CD-43D3-B3A6-B013C7D49214

Q30572367-9A46D556-7C10-4CA9-BF74-2D9D61BFB8E3

Q30572367-B691091D-9E3C-4D16-8DC1-E5B7A71B1090

Q30572367-C853F06D-52A6-4A01-BEEA-DAC2BD93E3E0

P2860

Q30572367-0505DC5C-A22C-4B0B-8393-788BF21A7DF9

Q30572367-0686C8EB-AFCF-44EF-9900-9547E7F894BD

Q30572367-0C3D85B1-1BE3-4499-9D4A-8FD7D7C5DA48

Q30572367-19784DDC-3A04-4A42-B108-14B50D6E8DAE

Q30572367-19E9C72C-126F-4A10-81D5-743F1E8B00BE

Q30572367-1AD04912-A5D1-4EBF-AF2A-DB00DE4CB251

Q30572367-1B1F14FA-8028-4242-BCA5-CF97AC5C9CBF

Q30572367-1CC29FE4-9B71-47CB-8BC1-DED3E665D43B

Q30572367-2B4BCF0F-AC6E-4566-B753-B99FC93B6E11

Q30572367-2CE0F092-AD90-4E8B-BF46-E3F9C210B32B

P2888

Q30572367-062B7FB4-1484-407A-A4B4-228BE997D225

P304

Q30572367-47D9F4DA-E743-4026-B1B7-09FE182063D1

P31

Q30572367-BB09E00D-553D-4BC5-8306-047F83FB9186

P356

Q30572367-1245112D-62A8-47F9-989E-BB4A0BC33460

P407

Q30572367-B1A3864B-EA96-4388-BEDF-D9F348F7681C

P433

Q30572367-8A44EB1A-7FA3-4C79-B059-49127D405B4D

P478

Q30572367-9D5BD794-24D2-4CF0-8A16-D5DE1AFDB093

P50

Q30572367-805416E3-70AD-4935-BA87-F20FB32127D8

Q30572367-81A929A8-5B50-4B12-ABE0-20D9A785FF60

P577

Q30572367-90B95830-4908-431B-8583-A1589F62A37D

P5875

Q30572367-CC0C437C-90EC-4A0D-B804-515C3C43A817

P698

Q30572367-F1E5B8CB-176B-4078-8B2A-415883B5058F

P921

Q30572367-13978d66-1520-4bca-a563-a1a37b235f36

P932

Q30572367-63A530F1-C8C1-46E8-959F-238E931BDBEC

P356

P1433

Nature Neuroscience

P1476

Brain tumor initiating cells a ...... gh preferential glucose uptake

@en

P2093

Andrew E Sloan

http://www.w3.org/2001/XMLSchema#string

Bryan W Day

http://www.w3.org/2001/XMLSchema#string

Ichiro Nakano

http://www.w3.org/2001/XMLSchema#string

Jann N Sarkaria

http://www.w3.org/2001/XMLSchema#string

Jeremy N Rich

http://www.w3.org/2001/XMLSchema#string

Justin D Lathia

http://www.w3.org/2001/XMLSchema#string

Masahiro Hitomi

http://www.w3.org/2001/XMLSchema#string

Meizhang Li

http://www.w3.org/2001/XMLSchema#string

Nasiha Rahim

http://www.w3.org/2001/XMLSchema#string

Qiulian Wu

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma

An integrated genomic analysis of human glioblastoma multiforme

IDH1 and IDH2 mutations in gliomas

Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1

Comprehensive genomic characterization defines human glioblastoma genes and core pathways

An inhibitor of mutant IDH1 delays growth and promotes differentiation of glioma cells.

Glioma stem cells promote radioresistance by preferential activation of the DNA damage response

Stem cells, cancer, and cancer stem cells

Identification of human brain tumour initiating cells

Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors

P2888

P304

1373-1382

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NN.3510

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P50

Brett W Stringer

Anita B Hjelmeland

P577

2013-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

256331674

http://www.w3.org/2001/XMLSchema#string

P698

23995067

http://www.w3.org/2001/XMLSchema#string

P921

P932

3930177

http://www.w3.org/2001/XMLSchema#string